{
    "2021-12-04": [
        [
            {
                "time": "",
                "original_text": "人福医药“归核化”成效不佳？",
                "features": {
                    "keywords": [
                        "人福医药",
                        "归核化",
                        "成效不佳"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医保谈判结果出炉后，市场反应如何？",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "结果",
                        "市场反应"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "74种药品“晋级”国家医保目录，多家上市公司产品榜上有名",
                "features": {
                    "keywords": [
                        "药品",
                        "晋级",
                        "国家医保目录",
                        "上市公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医保谈判平均降价61.71%，多个罕见病药物进入医保",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "降价",
                        "罕见病药物",
                        "进入医保"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医保谈判平均降价61.71% 多个罕见病药物进入医保",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "降价",
                        "罕见病药物",
                        "进入医保"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}